Ipilimumab Approval Highlights Immunotherapy Renaissance
On March 25, 2011, Yervoy® [ipilimumab] by Bristol-Myers Squibb became the eleventh mAb approved by the FDA for the treatment of cancer.
© 2013-2018 MDB Communications LLC. All Rights Reserved. Please read our Legal Disclaimer
Phone: (215) 310-8390